Mira Pharmaceuticals (MIRA) Change in Accured Expenses (2022 - 2025)

Mira Pharmaceuticals has reported Change in Accured Expenses for 4 years, with the latest figure at $45278.0 in Q4 2025.

• Quarterly Change in Accured Expenses rose 48.38% year-over-year to $45278.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$594146.0 (down 421.53% YoY) and the FY2025 annual result came in at -$594146.0, down 421.53% from the prior year.
• Change in Accured Expenses grew to $45278.0 in Q4 2025 per MIRA's latest filing, from -$214533.0 in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $347684.0 in Q3 2022 and troughed at -$617176.0 in Q1 2025.
• A 4-year average of -$19915.7 and a median of $71487.5 in 2024 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses jumped 132.76% in 2024, then sank 731.72% in 2025.
• Over 4 years, Change in Accured Expenses stood at $172381.0 in 2022, then plunged by 239.81% to -$241008.0 in 2023, then surged by 112.66% to $30515.0 in 2024, then surged by 48.38% to $45278.0 in 2025.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $45278.0, -$214533.0, and $192285.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.